Nalpropion Pharmaceuticals, Inc. v Actavis Laboratories FL, Inc (Fed. Cir. Aug. 15, 2019) is a precedential opinion written by Judge Lourie with Judge Wallach and a dissent from Judge Prost in a case centered on an ANDA litigation in which Actavis sought approval for their generic version to Nalpropion's patents for the Contrave® product. Footnote 1 in the opinion outlines the rather complex history of the ownership/license interests as they changed over time.

Derek Mason was interviewed by Michael Keating for a blog post entitled "Tips for Safeguarding Your Products from Fakes," featured in Industrial Equipment News (IEN).

Todd Baker will be a panelist at the "AIPLA on the Road: Latest on Patent Practice Board Before the USPTO and the PTAB - Alexandria" event, at the USPTO on August 27th, 2019.

Rob Mattson and Norman Oblon are attending the 2019 AIPPI World Congress conference in London, from September 15-18th. The International Association for the Protection of Intellectual Property, known as the AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle), is the world's leading International Organization dedicated to the development and the improvement of laws for the protection of intellectual property.

Oblon will sponsor the 7th Annual Pediatric Device Innovation Symposium, which takes place on September 22, 2019 in Boston, MA.

Eleven Oblon attorneys have been named to the 2020 edition of Best Lawyers in America.

Today, Oblon launched its Life Sciences blog, www.lifesciencesipblog.com , which is designed to report and comment on Intellectual property matters related to the life sciences industry.

Oblon was recognized by The Legal 500 as one of the America's leading firms in Patent Prosecution, Re-Examination and Post Grant Proceedings for the 11th straight year.